Challenges when designing qPCR/ddPCR assays for cell and gene therapies
In this webinar we will focus on qPCR/ddPCR assay challenges, approaches to overcome them and a future outlook on field evolution.
While designing a qPCR/ddPCR assay for supporting cell and gene therapies can be straight forward, there are also key challenges and complexities molecular bioanalytical scientists currently face in the process. This webinar will review and discuss these challenges and complexities via key examples, the approaches taken to overcome them to drive the best outcomes, as well as a future outlook on how the field continues to evolve.
What will you learn?
- Aspects to consider when designing and executing a qPCR/ddPCR assay
- Ways to address qPCR/ddPCR assay challenges
- A future glimpse of qPCR/ddPCR assay evolution
Who this may interest?
- Pharmaceutical and biotech researchers developing cell and gene therapies
- Scientists working in the field of molecular bioanalysis
Speaker
Tracy Iles
Global Head of Method Development, Molecular Bioanalytical Services
Labcorp Biopharma Laboratory Solutions (Harrogate, UK)
Tracy Iles brings more than 20 years of experience in the molecular bioanalytical field and in multiple CMC fields, including virology, bioassay and ELISA. She possesses specialized expertise in cell culture, cell-based assays, DNA/RNA isolation and qPCR/RT-qPCR/ddPCR. As the Global Head of Method Development for Molecular Bioanalysis for Labcorp Biopharmaceutical CMC Services, Tracy provides scientific leadership and technical guidance for Labcorp’s large molecule bioanalytical laboratories and partners with our clients in the development and validation of molecular biology assays throughout the drug development continuum. Additionally, Tracy obtained her BSc in biochemistry from the University of Reading (UK) and has been a member of the EBF qPCR team for several years.
This webinar was recorded 29 May 2024
In association with
